Catalent, Inc. Reports Fourth Quarter Fiscal 2019 Results

Go back to Catalent, Inc. Reports Fourth Quarter Fiscal 2019 Results

Catalent (CTLT) Tops Q4 EPS by 6c, Revenues Beat; Offers FY20 Revenue Outlook

August 27, 2019 7:34 AM EDT

Catalent (NYSE: CTLT) reported Q4 EPS of $0.70, $0.06 better than the analyst estimate of $0.64. Revenue for the quarter came in at $725.7 million versus the consensus estimate of $721.03 million.

Q4'19 revenue of $725.7 million increased 6% as-reported, or 8% in constant currency, from Q4'18.Full-year 2019 revenue of $2,518.0 million increased 2% as-reported, or 5% in constant currency, from the prior year.Closed the acquisition of biologics gene therapy CDMO Paragon Bioservices, Inc.Announced an agreement to purchase... More